Insulin increases sodium (Na+) channel density in A6 epithelia: implications for expression of hypertension.
Essential or primary hypertension is a multifactorial disease that is expressed as a result of complex interactions between genes and environmental influences. Several mutations in many different proteins are associated with expression of hypertension, including abnormalities in the epithelial sodium channel (ENaC) found in absorptive organs (i.e., distal colon, distal tubule of the nephron). Some of these mutations result in structural and/or functional alterations in ENaC-mediated Na+ entry in epithelia responsible for fluid and electrolyte balance and are associated with expression of hypertension. Studies support the notion that there is a link between ENaC and hypertension of both the monogenic (single gene mutation) and primary or essential type (a multifactorial disease). Alterations of other aspects of the environment of absorptive cells (e.g., hyperinsulinemia, hyperaldosteronemia, high plasma cortisol, high plasma Na+) have also been shown to elicit hyperabsorption of Na+ via ENaC and therefore could contribute significantly to expression of hypertension in people with intermediate phenotypes. This article describes an initial study in which the effects of an environmental factor, extracellular levels of insulin, on ENaC were examined in a normal kidney cell model. Electrophysiologic techniques revealed that ENaC density rapidly increased in response to addition of insulin to the basolateral bath. This autoregulatory recruitment of Na+ total channel density masked a slight decrease in open channel probability. Insulin's effect on ENaC function and implications on fluid and electrolyte balance and expression of primary hypertension is discussed.
Carter Center for HPE and Related Brain Malformations, Kennedy Krieger Institute, Baltimore, MD, USA.
L M
LM
Baxendale-Cox
R L
RL
Duncan
D000818:Animals; D002452:Cell Count; D002478:Cells, Cultured; D004195:Disease Models, Animal; D004848:Epithelium / Q000187:drug effects*; D005786:Gene Expression Regulation / Q000235:genetics*; D006706:Homeostasis / Q000187:drug effects; D006973:Hypertension / Q000139:chemically induced* / Q000235:genetics*; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D007328:Insulin / Q000009:adverse effects*; D007686:Kidney Tubules, Distal / Q000166:cytology*; D009154:Mutation / Q000235:genetics*; D011898:Ranidae; D012307:Risk Factors; D015222:Sodium Channels / Q000187:drug effects* / Q000648:ultrastructure; D014882:Water-Electrolyte Balance / Q000187:drug effects
D007004:Hypoglycemic Agents; D007328:Insulin; D015222:Sodium Channels